Additionally, a study that analysed survival of KRAS and BRAF mutant metastatic cancers following complete liver resection found that there were comparable overall survival rates although fewer data for BRAF mutant cancers was available [113]. The gene discussed is BRAF; the disease is metastatic malignant neoplasm.